SCHEMBL8048778

SCHEMBL8048778

COc1nc2c(OCc3c(Cl)ccc(N(C)C(=O)CN)c3Cl)cccc2n1C

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 17/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7978740 0.89 BDKRB2 (0.63) BDKRB2
SCHEMBL7965622 0.88 BDKRB2 (0.64) BDKRB2
SCHEMBL7975556 0.87 BDKRB2 (0.60) BDKRB2
SCHEMBL7978807 0.86 BDKRB2 (0.54) BDKRB2
SCHEMBL659552 0.85 BDKRB2 (0.67) BDKRB2
SCHEMBL7965449 0.82 BDKRB2 (0.64) BDKRB2
SCHEMBL7978850 0.81 BDKRB2 (0.82) BDKRB2
SCHEMBL7978853 0.81 BDKRB2 (0.82) BDKRB2
SCHEMBL7978824 0.80 BDKRB2 (0.56) BDKRB2
SCHEMBL7981712 0.80 BDKRB2 (0.84) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed